Polymeric nanoparticles in gene therapy: New avenues of design and optimization for delivery applications

R Rai, S Alwani, I Badea - Polymers, 2019 - mdpi.com
The field of polymeric nanoparticles is quickly expanding and playing a pivotal role in a wide
spectrum of areas ranging from electronics, photonics, conducting materials, and sensors to …

Phosphorothioates, essential components of therapeutic oligonucleotides

F Eckstein - Nucleic acid therapeutics, 2014 - liebertpub.com
Phosphorothioates have found their usefulness in the general area of oligonucleotide
therapeutic applications. Initially this modification was introduced into the antisense …

TF-PROTACs enable targeted degradation of transcription factors

J Liu, H Chen, HU Kaniskan, L **e… - Journal of the …, 2021 - ACS Publications
Transcription factors (TFs) represent a major class of therapeutic targets for the treatment of
human diseases including cancer. Although the biological functions and even crystal …

Oligonucleotide therapies: the past and the present

KE Lundin, O Gissberg, CIE Smith - Human gene therapy, 2015 - liebertpub.com
In this review we address the development of oligonucleotide (ON) medicines from a
historical perspective by listing the landmark discoveries in this field. The various biological …

Photoaging: mechanisms and repair

JH Rabe, AJ Mamelak, PJS McElgunn… - Journal of the American …, 2006 - Elsevier
Aging is a complex, multifactorial process resulting in several functional and esthetic
changes in the skin. These changes result from intrinsic as well as extrinsic processes, such …

New insights into the role of nuclear factor-κB, a ubiquitous transcription factor in the initiation of diseases

F Chen, V Castranova, X Shi, LM Demers - Clinical chemistry, 1999 - academic.oup.com
Nuclear factor-κB (NF-κB) is a ubiquitous transcription factor that governs the expression of
genes encoding cytokines, chemokines, growth factors, cell adhesion molecules, and some …

The Myc oncoprotein as a therapeutic target for human cancer

M Vita, M Henriksson - Seminars in cancer biology, 2006 - Elsevier
Myc expression is deregulated in a wide range of human cancers and is often associated
with aggressive, poorly differentiated tumors. The Myc protein is a transcription factor that …

[HTML][HTML] Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery

MS Conte, DF Bandyk, AW Clowes, GL Moneta… - Journal of vascular …, 2006 - Elsevier
OBJECTIVE: The PREVENT III study was a prospective, randomized, double-blinded,
multicenter phase III trial of a novel molecular therapy (edifoligide; E2F decoy) for the …

Aptamers and the next generation of diagnostic reagents

V Thiviyanathan, DG Gorenstein - PROTEOMICS–Clinical …, 2012 - Wiley Online Library
Antibodies have been extensively used as capture and detection reagents in diagnostic
applications of proteomics‐based technologies. Proteomic assays need high sensitivity and …

LNA: a versatile tool for therapeutics and genomics

M Petersen, J Wengel - Trends in biotechnology, 2003 - cell.com
Locked nucleic acid (LNA) is a nucleic acid analogue that displays unprecedented
hybridization affinity towards complementary DNA and RNA. Structural studies have shown …